Loading market dashboard

Financials in USD. Standardized financial statements.
A compact view of how Sirona Biochem Corp. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $34,779 | $671,923 | $268,022 | $105,711 | $135,743 | $1.28M | $5,468 | $360,500 | $7,995 | $207,737 |
| Revenue Growth? | -94.8% | +150.7% | +153.5% | -22.1% | -89.4% | +23285.1% | -98.5% | +4409.1% | -96.2% | 0.0% |
| Cost of Revenue? | $63,546 | $50,168 | $68,772 | $54,139 | $0 | $0 | $0 | $50,618 | $212,910 | $57,224 |
| Gross Profit? | -$28,767 | $621,755 | $199,250 | $51,572 | $135,743 | $1.28M | $5,468 | $309,882 | -$204,915 | $150,513 |
| Gross Margin? | -82.7% | +92.5% | +74.3% | +48.8% | +100.0% | +100.0% | +100.0% | +86.0% | -2563.0% | +72.5% |
| Operating Expenses? | $2.48M | $4.21M | $2.55M | $4.09M | $4.60M | $2.22M | $2.50M | $3.29M | $3.51M | $3.68M |
| Operating Income? | -$2.41M | -$3.57M | -$2.35M | -$4.04M | -$4.44M | -$911,980 | -$2.49M | -$2.93M | -$3.50M | -$3.48M |
| EBITDA? | -$2.33M | -$3.52M | -$2.30M | -$4.12M | $0 | -$911,980 | -$2.30M | -$2.79M | -$3.40M | -$3.46M |
| Income Before Tax | -$2.54M | -$3.55M | -$2.31M | -$4.14M | -$4.56M | -$1.15M | -$4.47M | -$2.97M | -$3.57M | -$3.56M |
| Income Tax Expense | -$954 | $5,954 | -$5,681 | -$7,076 | -$6,208 | $120,106 | -$10,796 | $0 | -$20,954 | -$36,037 |
| Net Income? | -$2.54M | -$3.56M | -$2.31M | -$4.13M | -$4.55M | -$1.27M | -$4.46M | -$2.97M | -$3.55M | -$3.53M |
| EPS? | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.03 | $-0.02 | $-0.03 | $-0.03 |
| Diluted EPS? | $-0.01 | $-0.01 | $-0.01 | $-0.02 | $-0.02 | $-0.01 | $-0.03 | $-0.02 | $-0.03 | $-0.03 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality